Pharmafile Logo
Pharmafocus logo
Advanced Search

Thermosome secures FDA Orphan Drug Designation for soft tissue sarcoma therapy

May 12, 2025
Research and Development European Medicines Agency (EMA), FDA, Oncology, Thermosome

Thermosome has received Orphan Drug Designation (ODD) from the US Food and Drug Administration (FDA) for its lead candidate, THE001, …

News
researchers_credit_neusentis_pfizer

Novo Nordisk unveils new semaglutide data on obesity and heart disease at ECO 2025

May 12, 2025
Research and Development Cardiology, Novo Nordisk, Obesity, Ozempic, cardiometabolic conditions, heart disease, obesity, semaglutide

Danish biopharma, Novo Nordisk, has announced that it will present new data on metabolic and cardiovascular health at the upcoming …

News

Moderna expands use of AI-ready R&D platform

May 12, 2025
Business Services, Research and Development, Technical Consultancy AI, Benchling, Corporate, Moderna, R&D, digital transformation

Moderna has expanded its partnership with Benchling, a cloud-based research platform, to support its broader research organisation. Previously used by …

News
bowel_cancer_screening

European Commission approves Johnson & Johnson’s Crohn’s disease therapy

May 12, 2025
Market Access, Research and Development, Sales and Marketing Crohn’s disease, European Commission, Gastrointestinal tract, Johnson & Johnson, guselkumab, marketing authorisation

The European Commission (EC) has granted Marketing Authorisation (MA) to Johnson & Johnson’s Tremfya (guselkumab) for the treatment of moderately …

News

Mind the gap: men’s health and the need for progress

May 12, 2025
Advocacy Development, Medical Communications, Medical Education, Research and Development Androlabs, Men's Health Strategy, Men's mental health, Movember Foundation, Pharmacy, Psychiatry, mental health

From prostate cancer to hormonal health, many areas of men’s health require more attention. As male life expectancy and healthy …

Feature
Thought Leadership

Galimedix completes key stage of clinical trial for treatment targeting eye and brain diseases

May 9, 2025
Research and Development Galimedix Therapeutics, Neurology, Opthalmology, R&D, clinical trial, neurodegenerative conditions

Clinical biotech, Galimedix Therapeutics, has announced the completion of a single ascending dose (SAD) part of a phase 1 study …

News

Apiary invests in life sciences SEO pioneer PIO to support global expansion

May 9, 2025
Agency, Business Services, Marketing Consultancies AI, Apiary Capital, Corporate, PIO, SEO, agency, investment, performance marketing, performance-io

Private equity firm Apiary Capital has invested in performance-io (PIO), a specialist life sciences performance marketing and SEO agency, to …

News

AAX Biotech announces collaboration for cardiovascular antibody therapy

May 8, 2025
Research and Development AAX Biotech, Cardiology, antibody therapies, collaboration, research and development

Swedish biotech firm AAX Biotech has entered a new collaboration focused on the development of antibody-based therapies targeting cardiovascular disease. …

News

Majority of Europeans trust technology to improve healthcare, Johnson & Johnson survey finds

May 8, 2025
Research and Development AI, Corporate, Devices, EU Data Act, HCPs, Johnson & Johnson, Pharmacy, digital technology, survey

A global survey by Johnson & Johnson MedTech has revealed that a majority of Europeans are willing to share their …

News

Bristol Myers Squibb appoints Cari Gallman as executive vice president, general counsel and chief policy officer

May 8, 2025
Business Services, Legal, Research and Development Corporate, appointment, bristol myers squibb

Global biopharma company, Bristol Myers Squibb, has announced the appointment of Cari Gallman as executive vice president, general counsel and …

Appointment

Digital Control Room, a major pharma provider, wins King’s Award for Enterprise

May 7, 2025
Business Services, Medical Communications Digital Control Room, King's Award for Enterprise, Pharma services, Pharmacy, UK

Buckingham Palace has announced that Digital Control Room, a software platform that monitors companies’ online content, will receive a King’s …

News

ENA Respiratory appoints two strategic advisors to support leading project

May 7, 2025
Research and Development Ena Respiratory, Infections and infestations, Respirology, strategic adivsors

ENA Respiratory, focused on minimising the impact of viral respiratory infections, has announced the appointment of Kenny Simmen (pictured left) …

Appointment
trialy

Alchemab Therapeutics signs $415m licensing agreement for ALS programme with Eli Lilly

May 7, 2025
Mergers and Acquisitions Alchemab Therapeutics, Corporate, Eli Lilly and Company, Immunology, M&A, als, immunology, neurodegenerative conditions

Alchemab Therapeutics, an immunotherapy-focused biopharma company, has entered a licensing agreement with Eli Lilly and Company (Lilly) for ATLX-1282, its …

News

Sanofi and CD&R finalise Opella deal, launching global consumer healthcare giant

May 6, 2025
Mergers and Acquisitions (OTC & VMS), Clayton, Clayton Dubilier & Rice (CD&R), Corporate, M&A, Opella, Sanofi, agreement

Sanofi and Clayton, Dubilier & Rice (CD&R) have officially closed the sale of a controlling 50% stake in Opella, Sanofi’s …

News

Genmab to submit FDA application for lymphoma therapy

May 2, 2025
Research and Development AbbVie, Biologics License Application, FDA, Genmab, Oncology, epcoritamab, lymphoma, therapeutics

Global biotechnology company Genmab plans to submit a supplemental Biologics License Application (sBLA) to the US Food and Drug Administration (FDA) …

News
researchers_credit_neusentis_pfizer

Ambitious plans for leading cancer research centre announced

May 2, 2025
Market & Product Development, Medical Communications, Research and Development Aviva Capital Partners (ACP), Institute of Cancer Research (ICR), London, London Cancer Hub, Oncology, Royal Marsden NHS Foundation Trust, Socius

Aviva Capital Partners (ACP), an infrastructure and real estate investor, and Socius, a mixed-use developer, have unveiled plans for a …

News

Clinigen announces executive appointments to drive growth and investor value

May 1, 2025
Business Services, Pharmaceutical Consultancy Services Clinigen, Keith Bryne, Nihad Hasagic, Pharma services, Pharmacy, appointment

Clinigen, the global pharmaceutical services group, has announced key leadership changes to accelerate its growth and strengthen its position in …

Appointment

Tozaro appoints Jason Slingsby as CEO to lead commercial strategy in cell and gene therapy sector

May 1, 2025
Manufacturing Services, Manufacturing and Production, Research and Development CEO, CGT, Jason Slingsby, Michele Pedrocchi, Pharmacy, Tozaro, manufacturing

Tozaro, a technology provider specialising in cell and gene therapy (CGT) manufacturing, has appointed Jason Slingsby (pictured left) as its …

Appointment

Deadly cancers are being financially left behind, new research claims

May 1, 2025
Research and Development Jude, Oncology, UK, bladder cancer, cancer research, charitable funding

New research has revealed that some of the UK’s most deadly and prevalent cancers receive the least amount of charitable …

News

Neogap chosen for Innovate Nordics 2025 Acceleration Programme

May 1, 2025
Research and Development Innovate Nordics, Neogap Therapeutics, Oncology, biotech, funding programme, immunotherapy

Swedish biotech company Neogap Therapeutics has been chosen to join Innovate Nordics’ 2025 acceleration programme, a prestigious initiative designed to …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026